Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure, function, and activation of coagulation factor VII.

Charles Eigenbrot1

  • 1Department of Protein Engineering, Genentech, Inc., South San Francisco, California, USA. eigenbrot.c@gene.com

Current Protein & Peptide Science
|August 22, 2002
PubMed
Summary

Factor VII (FVII) initiates blood coagulation. This review details its allosteric regulation and structural changes, including new insights from zymogen structures, crucial for understanding thrombosis and hemostasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.

Journal of medicinal chemistry·2022
Same author

Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.

Bioorganic & medicinal chemistry letters·2022
Same author

Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif.

Communications biology·2021
Same author

Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor.

ACS medicinal chemistry letters·2021
Same author

Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor.

Journal of medicinal chemistry·2021
Same author

Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge.

Nature communications·2020

Area of Science:

  • Biochemistry
  • Structural Biology
  • Hematology

Background:

  • Factor VII (FVII) is a key protease initiating the coagulation cascade.
  • Maintaining hemostasis requires balancing thrombosis and bleeding.
  • FVII is regulated by allosteric mechanisms involving cofactors, substrates, and inhibitors.

Purpose of the Study:

  • To review the allosteric behaviors of activated Factor VII (FVIIa).
  • To summarize structural findings of FVII and FVIIa since 1996.
  • To emphasize the significance of the recently determined FVII zymogen structure.

Main Methods:

  • Literature review of allosteric regulation in Factor VII.
  • Analysis of structural studies, including X-ray crystallography.
  • Integration of biochemical and structural data.

Related Experiment Videos

Main Results:

  • Allosteric sites on FVIIa have been identified and characterized.
  • Recent X-ray structures provide a 3D context for FVIIa function.
  • The structure of a FVII zymogen fragment offers new insights.

Conclusions:

  • Structural insights enhance understanding of FVIIa allosteric regulation.
  • The FVII zymogen structure is critical for interpreting allosteric mechanisms.
  • This knowledge is vital for developing anti-coagulant therapies.